Crohn’s disease can be debilitating and painful, so this is happy news indeed.
Via microsoft translate from Deredactie.be:
‘Those patients will now be able to be helped with Vedolizumab in the foreseeable future. So hot the new drug that blocks lymphocytes. That are white blood cells that in these patients flock to the intestine and cause inflammation.
Although medicines existed acting on lymphocytes, but those held in unacceptable risks because they not only the migration to the intestine, but also blocked to the brain. That often resulted in severe brain disorders.
“With the new drug, we managed to selectively block the migration of lymphocytes and to avoid these harmful side effects,” said gastro-enterologe Séverine Vermeire UZ Leuven.
It is expected that the drug in the course of next year will come on the European market.’